A RETROLECTIVE ANALYSIS ON THE SAFETY, EFFICACY AND IMMUNOGENICITY OF 203 GLIOBLASTOMA PATIENTS TREATED WITH PERSONALIZED THERAPEUTIC CANCER VACCINES (PTCV)

Category Primary study
JournalNeuro-Oncology
Year 2024
This article has no abstract
Epistemonikos ID: d1a4018bb0fa872801b8557af7971dba7927575a
First added on: Jan 08, 2025